Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(8 sites)
Sweden
Department of Obstetrics and Gynecology, Highland Hospital, Eksjö Department of Oncology, Sahlgrenska University Hospital, Gothenburg Department of Obstetrics and Gynecology, Ryhov County Hospital, Jönköping Department of Oncology, Linköping University Hospital, Linköping Department of Obstetrics and Gynaecology, Norrland University Hospital, Umeå Department of Obstetrics and Gynecology, Värnamo Hospital, Värnamo Department of Obstetrics and Gynecology, Västervik Hospital, Västervik Department of Obstetrics and Gynecology, University Hospital, Linköping, Östergötland County Last updated February 2025